Cognition and dorsolateral prefrontal cortex volume in corticosteroid- treated patients given lamotrigine

Saira Husain, Samuel Kuzminski, Mujeeb U. Shad, Barry Gabrielson, Mary E. Bret, I. Julian Osuji, E. Sherwood Brown

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In addition to changes in declarative memory and the hippocampus, corticosteroid excess is associated with prefrontal cortex changes. We previously reported that patients receiving exogenous corticosteroid therapy had impaired performance on prefrontal cortex-related tasks, including working memory and executive functioning tasks. Glutamate release inhibitors attenuate corticosteroid-effects on the hippocampus in both animal and human models. Twenty-eight outpatients receiving chronic prednisone therapy for transplant rejection or other medical conditions were randomized to lamotrigine (a glutamate release inhibitor) or placebo for 24 weeks. Dorsolateral prefrontal cortex (DLPFC) volume was manually traced from MRI scans by trained staff members. Cognition was examined using the Stroop Color Word Test (SCWT), Delis-Kaplan Executive Function System (D-KEFS) and the Trail Making Test. Groups were compared using analysis of covariance. Consistent with prior findings in corticosteroid-treated patients, baseline cognitive function was in the low normal range. At baseline, prednisone duration showed a trend towards negative correlation with SCWT and D-KEFS inhibition switching time error scores, and DLPFC volume showed a trend towards a positive correlation with SCWT scores. No significant between-group differences in outcomes were observed following lamotrigine therapy. Thus, this study found lamotrigine to not be associated with either positive or negative effects on cognition or DLPFC volume.

Original languageEnglish (US)
Pages (from-to)18-22
Number of pages5
JournalStress and Health
Volume27
Issue number1
DOIs
StatePublished - Feb 2011

Fingerprint

Prefrontal Cortex
Cognition
Adrenal Cortex Hormones
Color
Executive Function
Prednisone
Glutamic Acid
Hippocampus
Trail Making Test
Graft Rejection
Short-Term Memory
Reference Values
Outpatients
Therapeutics
Animal Models
Placebos
Magnetic Resonance Imaging
lamotrigine

Keywords

  • glutamate
  • lamotrigine
  • memory
  • prednisone
  • prefrontal cortex

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Applied Psychology
  • Clinical Psychology

Cite this

Cognition and dorsolateral prefrontal cortex volume in corticosteroid- treated patients given lamotrigine. / Husain, Saira; Kuzminski, Samuel; Shad, Mujeeb U.; Gabrielson, Barry; Bret, Mary E.; Osuji, I. Julian; Brown, E. Sherwood.

In: Stress and Health, Vol. 27, No. 1, 02.2011, p. 18-22.

Research output: Contribution to journalArticle

Husain, Saira ; Kuzminski, Samuel ; Shad, Mujeeb U. ; Gabrielson, Barry ; Bret, Mary E. ; Osuji, I. Julian ; Brown, E. Sherwood. / Cognition and dorsolateral prefrontal cortex volume in corticosteroid- treated patients given lamotrigine. In: Stress and Health. 2011 ; Vol. 27, No. 1. pp. 18-22.
@article{74dcb89c81764028a8b69dad6d10f671,
title = "Cognition and dorsolateral prefrontal cortex volume in corticosteroid- treated patients given lamotrigine",
abstract = "In addition to changes in declarative memory and the hippocampus, corticosteroid excess is associated with prefrontal cortex changes. We previously reported that patients receiving exogenous corticosteroid therapy had impaired performance on prefrontal cortex-related tasks, including working memory and executive functioning tasks. Glutamate release inhibitors attenuate corticosteroid-effects on the hippocampus in both animal and human models. Twenty-eight outpatients receiving chronic prednisone therapy for transplant rejection or other medical conditions were randomized to lamotrigine (a glutamate release inhibitor) or placebo for 24 weeks. Dorsolateral prefrontal cortex (DLPFC) volume was manually traced from MRI scans by trained staff members. Cognition was examined using the Stroop Color Word Test (SCWT), Delis-Kaplan Executive Function System (D-KEFS) and the Trail Making Test. Groups were compared using analysis of covariance. Consistent with prior findings in corticosteroid-treated patients, baseline cognitive function was in the low normal range. At baseline, prednisone duration showed a trend towards negative correlation with SCWT and D-KEFS inhibition switching time error scores, and DLPFC volume showed a trend towards a positive correlation with SCWT scores. No significant between-group differences in outcomes were observed following lamotrigine therapy. Thus, this study found lamotrigine to not be associated with either positive or negative effects on cognition or DLPFC volume.",
keywords = "glutamate, lamotrigine, memory, prednisone, prefrontal cortex",
author = "Saira Husain and Samuel Kuzminski and Shad, {Mujeeb U.} and Barry Gabrielson and Bret, {Mary E.} and Osuji, {I. Julian} and Brown, {E. Sherwood}",
year = "2011",
month = "2",
doi = "10.1002/smi.1308",
language = "English (US)",
volume = "27",
pages = "18--22",
journal = "Stress and Health",
issn = "1532-2998",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Cognition and dorsolateral prefrontal cortex volume in corticosteroid- treated patients given lamotrigine

AU - Husain, Saira

AU - Kuzminski, Samuel

AU - Shad, Mujeeb U.

AU - Gabrielson, Barry

AU - Bret, Mary E.

AU - Osuji, I. Julian

AU - Brown, E. Sherwood

PY - 2011/2

Y1 - 2011/2

N2 - In addition to changes in declarative memory and the hippocampus, corticosteroid excess is associated with prefrontal cortex changes. We previously reported that patients receiving exogenous corticosteroid therapy had impaired performance on prefrontal cortex-related tasks, including working memory and executive functioning tasks. Glutamate release inhibitors attenuate corticosteroid-effects on the hippocampus in both animal and human models. Twenty-eight outpatients receiving chronic prednisone therapy for transplant rejection or other medical conditions were randomized to lamotrigine (a glutamate release inhibitor) or placebo for 24 weeks. Dorsolateral prefrontal cortex (DLPFC) volume was manually traced from MRI scans by trained staff members. Cognition was examined using the Stroop Color Word Test (SCWT), Delis-Kaplan Executive Function System (D-KEFS) and the Trail Making Test. Groups were compared using analysis of covariance. Consistent with prior findings in corticosteroid-treated patients, baseline cognitive function was in the low normal range. At baseline, prednisone duration showed a trend towards negative correlation with SCWT and D-KEFS inhibition switching time error scores, and DLPFC volume showed a trend towards a positive correlation with SCWT scores. No significant between-group differences in outcomes were observed following lamotrigine therapy. Thus, this study found lamotrigine to not be associated with either positive or negative effects on cognition or DLPFC volume.

AB - In addition to changes in declarative memory and the hippocampus, corticosteroid excess is associated with prefrontal cortex changes. We previously reported that patients receiving exogenous corticosteroid therapy had impaired performance on prefrontal cortex-related tasks, including working memory and executive functioning tasks. Glutamate release inhibitors attenuate corticosteroid-effects on the hippocampus in both animal and human models. Twenty-eight outpatients receiving chronic prednisone therapy for transplant rejection or other medical conditions were randomized to lamotrigine (a glutamate release inhibitor) or placebo for 24 weeks. Dorsolateral prefrontal cortex (DLPFC) volume was manually traced from MRI scans by trained staff members. Cognition was examined using the Stroop Color Word Test (SCWT), Delis-Kaplan Executive Function System (D-KEFS) and the Trail Making Test. Groups were compared using analysis of covariance. Consistent with prior findings in corticosteroid-treated patients, baseline cognitive function was in the low normal range. At baseline, prednisone duration showed a trend towards negative correlation with SCWT and D-KEFS inhibition switching time error scores, and DLPFC volume showed a trend towards a positive correlation with SCWT scores. No significant between-group differences in outcomes were observed following lamotrigine therapy. Thus, this study found lamotrigine to not be associated with either positive or negative effects on cognition or DLPFC volume.

KW - glutamate

KW - lamotrigine

KW - memory

KW - prednisone

KW - prefrontal cortex

UR - http://www.scopus.com/inward/record.url?scp=79551553861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551553861&partnerID=8YFLogxK

U2 - 10.1002/smi.1308

DO - 10.1002/smi.1308

M3 - Article

AN - SCOPUS:79551553861

VL - 27

SP - 18

EP - 22

JO - Stress and Health

JF - Stress and Health

SN - 1532-2998

IS - 1

ER -